Marketing of Shockwave Therapy for Erectile Dysfunction Raises Concerns


MONDAY, April 18, 2022 (HealthDay News) — Shockwave therapy (SWT) as a restorative treatment for erectile dysfunction (ED), for which no standardized protocol has been developed, is being marketed directly to consumers, according to a study published online April 5 in Practice of Urology. James M. Weinberger, MD, of the David Geffen School of Medicine at the University of California, Los Angeles, and colleagues assessed trends in the marketing and implementation of SWT as a restorative treatment for dysfunction erectile in the eight largest metropolitan areas in the United States. Clinics were contacted by telephone using a ‘secret client’ methodology to identify the price, duration and provider administering the treatment. The researchers identified 152 clinics that offered SWT as a treatment for erectile dysfunction. Just under two-thirds of clinics (65%) provided complete information. A quarter of providers offering SWT were urologists, while 13% were non-physicians. Per course of treatment, the average price was $3,338.28. There was great variability in the duration of treatment, which varied from one course to indefinite courses depending on the patient’s individual situation. “This study highlights concerning trends in major metropolitan markets, given the substantial financial impact for patients and inconsistent referrals between providers,” the authors write. One author disclosed financial ties to Boston Scientific and Endo. Abstract/Full text (subscription or payment may be required) Copyright © 2022 HealthDay. All rights reserved.

Leave a Reply

Your email address will not be published.